Trending

#experimentAversion

Latest posts tagged with #experimentAversion on Bluesky

Posts tagged #experimentAversion

Rosenbaum, Gail, Amir Goren, Maheen Shermohammed, Donna M. Wolk, Ann Marie Tice, Joseph Doyle, Michelle Meyer, and Christopher F. Chabris. “Algorithm Aversion or Appreciation? Three Randomized Field Trials of Personalized Risk-Communication Nudges to Encourage Flu Vaccination,” June 22, 2023. https://doi.org/10.31234/osf.io/vtxza.

Rosenbaum, Gail, Amir Goren, Maheen Shermohammed, Donna M. Wolk, Ann Marie Tice, Joseph Doyle, Michelle Meyer, and Christopher F. Chabris. “Algorithm Aversion or Appreciation? Three Randomized Field Trials of Personalized Risk-Communication Nudges to Encourage Flu Vaccination,” June 22, 2023. https://doi.org/10.31234/osf.io/vtxza.

Vogt, R. L., Heck, P. R., Mestechkin, R. M., Heydari, P., Chabris, C. F., & Meyer, M. N. (2024). Aversion to pragmatic randomised controlled trials: Three survey experiments with clinicians and laypeople in the USA. BMJ Open, 14(9), e084699. https://doi.org/10.1136/bmjopen-2024-084699

Vogt, R. L., Heck, P. R., Mestechkin, R. M., Heydari, P., Chabris, C. F., & Meyer, M. N. (2024). Aversion to pragmatic randomised controlled trials: Three survey experiments with clinicians and laypeople in the USA. BMJ Open, 14(9), e084699. https://doi.org/10.1136/bmjopen-2024-084699

Title: Algorithm aversion or appreciation? Four randomized field trials of personalized riskcommunication nudges to encourage flu vaccination Authors: Christopher F. Chabris, Gail M. Rosenbaum, Amir Goren, Maheen Shermohammed, Donna M. Wolk, Ann Marie Tice, Joseph Doyle, Michelle N. Meyer

Title: Algorithm aversion or appreciation? Four randomized field trials of personalized riskcommunication nudges to encourage flu vaccination Authors: Christopher F. Chabris, Gail M. Rosenbaum, Amir Goren, Maheen Shermohammed, Donna M. Wolk, Ann Marie Tice, Joseph Doyle, Michelle N. Meyer

Title: Timely nudges promote patient portal enrollment and sustained engagement: Evidence from a prospective randomized trial Authors: Amir Goren, Sasha C. Brietzke, Maheen Shermohammed, Gail M. Rosenbaum, Michelle N. Meyer, Christopher F. Chabris

Title: Timely nudges promote patient portal enrollment and sustained engagement: Evidence from a prospective randomized trial Authors: Amir Goren, Sasha C. Brietzke, Maheen Shermohammed, Gail M. Rosenbaum, Michelle N. Meyer, Christopher F. Chabris

#HealthScience is alive and well at #Geisinger!

Some #Research Symposium highlights
- #GLP1 protocol testing
- #AI-assisted #risk assessment
- #experimentAversion
- #health #nudges
- Dr. Todd Rice on #Vanderbilt's pragmatic trials

Abstracts + #dataViz: ugc.production.linkt...

0 0 0 0
Figure 3. Clinician sentiments about COVID-19 pragmatic randomised controlled trials (pRCTs). (A) Mean appropriateness ratings, on a 1–5 scale, with standard errors, for intervention A, intervention B, the highest-rated intervention, the average intervention, the lowest-rated intervention and the A/B test. Circles represent measures directly collected from participants. Triangles represent averages derived from the direct measures. The distance of the mean appropriateness of the lowest-rated intervention (brown triangle) minus the mean appropriateness of the A/B test (orange circle) represents experiment aversion. The distance of the mean appropriateness of the average intervention (gray triangle) minus the mean appropriateness of the A/B test (orange circle) represents the A/B effect. The distance of the mean appropriateness of the A/B test (orange circle) minus the mean appropriateness of the highest-rated intervention (purple triangle) represents experiment appreciation.

(B) Appropriateness ratings transformed into percentages and standard errors of participants objecting (defined as assigning a rating of 1 or 2—‘very inappropriate’ or ‘somewhat inappropriate’— on a 1–5 scale) to implementing intervention A, intervention B and the A/B test.

Vogt, R. L., Heck, P. R., Mestechkin, R. M., Heydari, P., Chabris, C. F., & Meyer, M. N. (2024). Aversion to pragmatic randomised controlled trials: Three survey experiments with clinicians and laypeople in the USA. BMJ Open, 14(9), e084699. https://doi.org/10.1136/bmjopen-2024-084699

Figure 3. Clinician sentiments about COVID-19 pragmatic randomised controlled trials (pRCTs). (A) Mean appropriateness ratings, on a 1–5 scale, with standard errors, for intervention A, intervention B, the highest-rated intervention, the average intervention, the lowest-rated intervention and the A/B test. Circles represent measures directly collected from participants. Triangles represent averages derived from the direct measures. The distance of the mean appropriateness of the lowest-rated intervention (brown triangle) minus the mean appropriateness of the A/B test (orange circle) represents experiment aversion. The distance of the mean appropriateness of the average intervention (gray triangle) minus the mean appropriateness of the A/B test (orange circle) represents the A/B effect. The distance of the mean appropriateness of the A/B test (orange circle) minus the mean appropriateness of the highest-rated intervention (purple triangle) represents experiment appreciation. (B) Appropriateness ratings transformed into percentages and standard errors of participants objecting (defined as assigning a rating of 1 or 2—‘very inappropriate’ or ‘somewhat inappropriate’— on a 1–5 scale) to implementing intervention A, intervention B and the A/B test. Vogt, R. L., Heck, P. R., Mestechkin, R. M., Heydari, P., Chabris, C. F., & Meyer, M. N. (2024). Aversion to pragmatic randomised controlled trials: Three survey experiments with clinicians and laypeople in the USA. BMJ Open, 14(9), e084699. https://doi.org/10.1136/bmjopen-2024-084699

One premise in the argument 👆 seemed risky: randomly selecting between two seemingly equally acceptable treatments is NOT a sufficient justification to select one or the other treatment.

When asked, the reason for this #experimentAversion bias (doi.org/10.1136/bmjo...) was intuition and status quo.

1 0 1 0